Global Immune Drugs Market Growth 2026-2032
The global Immune Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Immune Drugs Industry Forecast? looks at past sales and reviews total world Immune Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Immune Drugs sales for 2026 through 2032. With Immune Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immune Drugs industry.
This Insight Report provides a comprehensive analysis of the global Immune Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immune Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Immune Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immune Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immune Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Immune Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Immune Drugs Industry Forecast? looks at past sales and reviews total world Immune Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Immune Drugs sales for 2026 through 2032. With Immune Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immune Drugs industry.
This Insight Report provides a comprehensive analysis of the global Immune Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immune Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Immune Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immune Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immune Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Immune Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Immune Boosting Drugs
- Immunosuppressant Drugs
- Hospital
- Clinic
- Surgery Center
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Antares Pharma, Inc.
- UCB
- Incyte
- GSK
- Takeda
- 3S Bio
- Horizo??n Therapeutics
- Bristol-Myers Squibb (BMS
- Astellas
- Eli Lilly
- Mitsubishi Tanabe Pharma
- Biogen
- Pfizer
- Sanofi
- Roche
- Novartis
- Johnson & Johnson (J&J)
- Amgen
- Abbvi
- What is the 10-year outlook for the global Immune Drugs market?
- What factors are driving Immune Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Immune Drugs market opportunities vary by end market size?
- How does Immune Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immune Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Immune Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Immune Drugs by Country/Region, 2021, 2025 & 2032
2.2 Immune Drugs Segment by Type
2.2.1 Immune Boosting Drugs
2.2.2 Immunosuppressant Drugs
2.2.3 Immune Drugs Sales by Type
2.2.3.1 Global Immune Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global Immune Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Immune Drugs Sale Price by Type (2021-2026)
2.3 Immune Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Surgery Center
2.3.4 Others
2.3.5 Immune Drugs Sales by Application
2.3.5.1 Global Immune Drugs Sale Market Share by Application (2021-2026)
2.3.5.2 Global Immune Drugs Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Immune Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Immune Drugs Breakdown Data by Company
3.1.1 Global Immune Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Immune Drugs Sales Market Share by Company (2021-2026)
3.2 Global Immune Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Immune Drugs Revenue by Company (2021-2026)
3.2.2 Global Immune Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Immune Drugs Sale Price by Company
3.4 Key Manufacturers Immune Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immune Drugs Product Location Distribution
3.4.2 Players Immune Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IMMUNE DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Immune Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Immune Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Immune Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Immune Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Immune Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Immune Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Immune Drugs Sales Growth
4.4 APAC Immune Drugs Sales Growth
4.5 Europe Immune Drugs Sales Growth
4.6 Middle East & Africa Immune Drugs Sales Growth
5 AMERICAS
5.1 Americas Immune Drugs Sales by Country
5.1.1 Americas Immune Drugs Sales by Country (2021-2026)
5.1.2 Americas Immune Drugs Revenue by Country (2021-2026)
5.2 Americas Immune Drugs Sales by Type (2021-2026)
5.3 Americas Immune Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immune Drugs Sales by Region
6.1.1 APAC Immune Drugs Sales by Region (2021-2026)
6.1.2 APAC Immune Drugs Revenue by Region (2021-2026)
6.2 APAC Immune Drugs Sales by Type (2021-2026)
6.3 APAC Immune Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Immune Drugs by Country
7.1.1 Europe Immune Drugs Sales by Country (2021-2026)
7.1.2 Europe Immune Drugs Revenue by Country (2021-2026)
7.2 Europe Immune Drugs Sales by Type (2021-2026)
7.3 Europe Immune Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immune Drugs by Country
8.1.1 Middle East & Africa Immune Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Immune Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Immune Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Immune Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immune Drugs
10.3 Manufacturing Process Analysis of Immune Drugs
10.4 Industry Chain Structure of Immune Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immune Drugs Distributors
11.3 Immune Drugs Customer
12 WORLD FORECAST REVIEW FOR IMMUNE DRUGS BY GEOGRAPHIC REGION
12.1 Global Immune Drugs Market Size Forecast by Region
12.1.1 Global Immune Drugs Forecast by Region (2027-2032)
12.1.2 Global Immune Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Immune Drugs Forecast by Type (2027-2032)
12.7 Global Immune Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Antares Pharma, Inc.
13.1.1 Antares Pharma, Inc. Company Information
13.1.2 Antares Pharma, Inc. Immune Drugs Product Portfolios and Specifications
13.1.3 Antares Pharma, Inc. Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Antares Pharma, Inc. Main Business Overview
13.1.5 Antares Pharma, Inc. Latest Developments
13.2 UCB
13.2.1 UCB Company Information
13.2.2 UCB Immune Drugs Product Portfolios and Specifications
13.2.3 UCB Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 UCB Main Business Overview
13.2.5 UCB Latest Developments
13.3 Incyte
13.3.1 Incyte Company Information
13.3.2 Incyte Immune Drugs Product Portfolios and Specifications
13.3.3 Incyte Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Incyte Main Business Overview
13.3.5 Incyte Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK Immune Drugs Product Portfolios and Specifications
13.4.3 GSK Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Immune Drugs Product Portfolios and Specifications
13.5.3 Takeda Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 3S Bio
13.6.1 3S Bio Company Information
13.6.2 3S Bio Immune Drugs Product Portfolios and Specifications
13.6.3 3S Bio Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 3S Bio Main Business Overview
13.6.5 3S Bio Latest Developments
13.7 Horizo??n Therapeutics
13.7.1 Horizo??n Therapeutics Company Information
13.7.2 Horizo??n Therapeutics Immune Drugs Product Portfolios and Specifications
13.7.3 Horizo??n Therapeutics Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Horizo??n Therapeutics Main Business Overview
13.7.5 Horizo??n Therapeutics Latest Developments
13.8 Bristol-Myers Squibb (BMS
13.8.1 Bristol-Myers Squibb (BMS Company Information
13.8.2 Bristol-Myers Squibb (BMS Immune Drugs Product Portfolios and Specifications
13.8.3 Bristol-Myers Squibb (BMS Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bristol-Myers Squibb (BMS Main Business Overview
13.8.5 Bristol-Myers Squibb (BMS Latest Developments
13.9 Astellas
13.9.1 Astellas Company Information
13.9.2 Astellas Immune Drugs Product Portfolios and Specifications
13.9.3 Astellas Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Astellas Main Business Overview
13.9.5 Astellas Latest Developments
13.10 Eli Lilly
13.10.1 Eli Lilly Company Information
13.10.2 Eli Lilly Immune Drugs Product Portfolios and Specifications
13.10.3 Eli Lilly Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Eli Lilly Main Business Overview
13.10.5 Eli Lilly Latest Developments
13.11 Mitsubishi Tanabe Pharma
13.11.1 Mitsubishi Tanabe Pharma Company Information
13.11.2 Mitsubishi Tanabe Pharma Immune Drugs Product Portfolios and Specifications
13.11.3 Mitsubishi Tanabe Pharma Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Mitsubishi Tanabe Pharma Main Business Overview
13.11.5 Mitsubishi Tanabe Pharma Latest Developments
13.12 Biogen
13.12.1 Biogen Company Information
13.12.2 Biogen Immune Drugs Product Portfolios and Specifications
13.12.3 Biogen Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Biogen Main Business Overview
13.12.5 Biogen Latest Developments
13.13 Pfizer
13.13.1 Pfizer Company Information
13.13.2 Pfizer Immune Drugs Product Portfolios and Specifications
13.13.3 Pfizer Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Pfizer Main Business Overview
13.13.5 Pfizer Latest Developments
13.14 Sanofi
13.14.1 Sanofi Company Information
13.14.2 Sanofi Immune Drugs Product Portfolios and Specifications
13.14.3 Sanofi Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sanofi Main Business Overview
13.14.5 Sanofi Latest Developments
13.15 Roche
13.15.1 Roche Company Information
13.15.2 Roche Immune Drugs Product Portfolios and Specifications
13.15.3 Roche Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Roche Main Business Overview
13.15.5 Roche Latest Developments
13.16 Novartis
13.16.1 Novartis Company Information
13.16.2 Novartis Immune Drugs Product Portfolios and Specifications
13.16.3 Novartis Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Novartis Main Business Overview
13.16.5 Novartis Latest Developments
13.17 Johnson & Johnson (J&J)
13.17.1 Johnson & Johnson (J&J) Company Information
13.17.2 Johnson & Johnson (J&J) Immune Drugs Product Portfolios and Specifications
13.17.3 Johnson & Johnson (J&J) Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Johnson & Johnson (J&J) Main Business Overview
13.17.5 Johnson & Johnson (J&J) Latest Developments
13.18 Amgen
13.18.1 Amgen Company Information
13.18.2 Amgen Immune Drugs Product Portfolios and Specifications
13.18.3 Amgen Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Amgen Main Business Overview
13.18.5 Amgen Latest Developments
13.19 Abbvi
13.19.1 Abbvi Company Information
13.19.2 Abbvi Immune Drugs Product Portfolios and Specifications
13.19.3 Abbvi Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Abbvi Main Business Overview
13.19.5 Abbvi Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immune Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Immune Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Immune Drugs by Country/Region, 2021, 2025 & 2032
2.2 Immune Drugs Segment by Type
2.2.1 Immune Boosting Drugs
2.2.2 Immunosuppressant Drugs
2.2.3 Immune Drugs Sales by Type
2.2.3.1 Global Immune Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global Immune Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Immune Drugs Sale Price by Type (2021-2026)
2.3 Immune Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Surgery Center
2.3.4 Others
2.3.5 Immune Drugs Sales by Application
2.3.5.1 Global Immune Drugs Sale Market Share by Application (2021-2026)
2.3.5.2 Global Immune Drugs Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Immune Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Immune Drugs Breakdown Data by Company
3.1.1 Global Immune Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Immune Drugs Sales Market Share by Company (2021-2026)
3.2 Global Immune Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Immune Drugs Revenue by Company (2021-2026)
3.2.2 Global Immune Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Immune Drugs Sale Price by Company
3.4 Key Manufacturers Immune Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immune Drugs Product Location Distribution
3.4.2 Players Immune Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IMMUNE DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Immune Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Immune Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Immune Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Immune Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Immune Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Immune Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Immune Drugs Sales Growth
4.4 APAC Immune Drugs Sales Growth
4.5 Europe Immune Drugs Sales Growth
4.6 Middle East & Africa Immune Drugs Sales Growth
5 AMERICAS
5.1 Americas Immune Drugs Sales by Country
5.1.1 Americas Immune Drugs Sales by Country (2021-2026)
5.1.2 Americas Immune Drugs Revenue by Country (2021-2026)
5.2 Americas Immune Drugs Sales by Type (2021-2026)
5.3 Americas Immune Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immune Drugs Sales by Region
6.1.1 APAC Immune Drugs Sales by Region (2021-2026)
6.1.2 APAC Immune Drugs Revenue by Region (2021-2026)
6.2 APAC Immune Drugs Sales by Type (2021-2026)
6.3 APAC Immune Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Immune Drugs by Country
7.1.1 Europe Immune Drugs Sales by Country (2021-2026)
7.1.2 Europe Immune Drugs Revenue by Country (2021-2026)
7.2 Europe Immune Drugs Sales by Type (2021-2026)
7.3 Europe Immune Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immune Drugs by Country
8.1.1 Middle East & Africa Immune Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Immune Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Immune Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Immune Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immune Drugs
10.3 Manufacturing Process Analysis of Immune Drugs
10.4 Industry Chain Structure of Immune Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immune Drugs Distributors
11.3 Immune Drugs Customer
12 WORLD FORECAST REVIEW FOR IMMUNE DRUGS BY GEOGRAPHIC REGION
12.1 Global Immune Drugs Market Size Forecast by Region
12.1.1 Global Immune Drugs Forecast by Region (2027-2032)
12.1.2 Global Immune Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Immune Drugs Forecast by Type (2027-2032)
12.7 Global Immune Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Antares Pharma, Inc.
13.1.1 Antares Pharma, Inc. Company Information
13.1.2 Antares Pharma, Inc. Immune Drugs Product Portfolios and Specifications
13.1.3 Antares Pharma, Inc. Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Antares Pharma, Inc. Main Business Overview
13.1.5 Antares Pharma, Inc. Latest Developments
13.2 UCB
13.2.1 UCB Company Information
13.2.2 UCB Immune Drugs Product Portfolios and Specifications
13.2.3 UCB Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 UCB Main Business Overview
13.2.5 UCB Latest Developments
13.3 Incyte
13.3.1 Incyte Company Information
13.3.2 Incyte Immune Drugs Product Portfolios and Specifications
13.3.3 Incyte Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Incyte Main Business Overview
13.3.5 Incyte Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK Immune Drugs Product Portfolios and Specifications
13.4.3 GSK Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Immune Drugs Product Portfolios and Specifications
13.5.3 Takeda Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 3S Bio
13.6.1 3S Bio Company Information
13.6.2 3S Bio Immune Drugs Product Portfolios and Specifications
13.6.3 3S Bio Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 3S Bio Main Business Overview
13.6.5 3S Bio Latest Developments
13.7 Horizo??n Therapeutics
13.7.1 Horizo??n Therapeutics Company Information
13.7.2 Horizo??n Therapeutics Immune Drugs Product Portfolios and Specifications
13.7.3 Horizo??n Therapeutics Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Horizo??n Therapeutics Main Business Overview
13.7.5 Horizo??n Therapeutics Latest Developments
13.8 Bristol-Myers Squibb (BMS
13.8.1 Bristol-Myers Squibb (BMS Company Information
13.8.2 Bristol-Myers Squibb (BMS Immune Drugs Product Portfolios and Specifications
13.8.3 Bristol-Myers Squibb (BMS Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bristol-Myers Squibb (BMS Main Business Overview
13.8.5 Bristol-Myers Squibb (BMS Latest Developments
13.9 Astellas
13.9.1 Astellas Company Information
13.9.2 Astellas Immune Drugs Product Portfolios and Specifications
13.9.3 Astellas Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Astellas Main Business Overview
13.9.5 Astellas Latest Developments
13.10 Eli Lilly
13.10.1 Eli Lilly Company Information
13.10.2 Eli Lilly Immune Drugs Product Portfolios and Specifications
13.10.3 Eli Lilly Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Eli Lilly Main Business Overview
13.10.5 Eli Lilly Latest Developments
13.11 Mitsubishi Tanabe Pharma
13.11.1 Mitsubishi Tanabe Pharma Company Information
13.11.2 Mitsubishi Tanabe Pharma Immune Drugs Product Portfolios and Specifications
13.11.3 Mitsubishi Tanabe Pharma Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Mitsubishi Tanabe Pharma Main Business Overview
13.11.5 Mitsubishi Tanabe Pharma Latest Developments
13.12 Biogen
13.12.1 Biogen Company Information
13.12.2 Biogen Immune Drugs Product Portfolios and Specifications
13.12.3 Biogen Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Biogen Main Business Overview
13.12.5 Biogen Latest Developments
13.13 Pfizer
13.13.1 Pfizer Company Information
13.13.2 Pfizer Immune Drugs Product Portfolios and Specifications
13.13.3 Pfizer Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Pfizer Main Business Overview
13.13.5 Pfizer Latest Developments
13.14 Sanofi
13.14.1 Sanofi Company Information
13.14.2 Sanofi Immune Drugs Product Portfolios and Specifications
13.14.3 Sanofi Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sanofi Main Business Overview
13.14.5 Sanofi Latest Developments
13.15 Roche
13.15.1 Roche Company Information
13.15.2 Roche Immune Drugs Product Portfolios and Specifications
13.15.3 Roche Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Roche Main Business Overview
13.15.5 Roche Latest Developments
13.16 Novartis
13.16.1 Novartis Company Information
13.16.2 Novartis Immune Drugs Product Portfolios and Specifications
13.16.3 Novartis Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Novartis Main Business Overview
13.16.5 Novartis Latest Developments
13.17 Johnson & Johnson (J&J)
13.17.1 Johnson & Johnson (J&J) Company Information
13.17.2 Johnson & Johnson (J&J) Immune Drugs Product Portfolios and Specifications
13.17.3 Johnson & Johnson (J&J) Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Johnson & Johnson (J&J) Main Business Overview
13.17.5 Johnson & Johnson (J&J) Latest Developments
13.18 Amgen
13.18.1 Amgen Company Information
13.18.2 Amgen Immune Drugs Product Portfolios and Specifications
13.18.3 Amgen Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Amgen Main Business Overview
13.18.5 Amgen Latest Developments
13.19 Abbvi
13.19.1 Abbvi Company Information
13.19.2 Abbvi Immune Drugs Product Portfolios and Specifications
13.19.3 Abbvi Immune Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Abbvi Main Business Overview
13.19.5 Abbvi Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Immune Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Immune Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immune Boosting Drugs
Table 4. Major Players of Immunosuppressant Drugs
Table 5. Global Immune Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Immune Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Immune Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Immune Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Immune Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Immune Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Immune Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Immune Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Immune Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Immune Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Immune Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Immune Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Immune Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Immune Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Immune Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Immune Drugs Producing Area Distribution and Sales Area
Table 21. Players Immune Drugs Products Offered
Table 22. Immune Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Immune Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Immune Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Immune Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Immune Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Immune Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Immune Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Immune Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Immune Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Immune Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Immune Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Immune Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Immune Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Immune Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Immune Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Immune Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Immune Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Immune Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Immune Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Immune Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Immune Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Immune Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Immune Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Immune Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Immune Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Immune Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Immune Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Immune Drugs
Table 52. Key Market Challenges & Risks of Immune Drugs
Table 53. Key Industry Trends of Immune Drugs
Table 54. Immune Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Immune Drugs Distributors List
Table 57. Immune Drugs Customer List
Table 58. Global Immune Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Immune Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Immune Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Immune Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Immune Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Immune Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Immune Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Immune Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Immune Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Immune Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Immune Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Immune Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Immune Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Immune Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Antares Pharma, Inc. Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Antares Pharma, Inc. Immune Drugs Product Portfolios and Specifications
Table 74. Antares Pharma, Inc. Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Antares Pharma, Inc. Main Business
Table 76. Antares Pharma, Inc. Latest Developments
Table 77. UCB Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. UCB Immune Drugs Product Portfolios and Specifications
Table 79. UCB Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. UCB Main Business
Table 81. UCB Latest Developments
Table 82. Incyte Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Incyte Immune Drugs Product Portfolios and Specifications
Table 84. Incyte Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Incyte Main Business
Table 86. Incyte Latest Developments
Table 87. GSK Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. GSK Immune Drugs Product Portfolios and Specifications
Table 89. GSK Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. GSK Main Business
Table 91. GSK Latest Developments
Table 92. Takeda Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Takeda Immune Drugs Product Portfolios and Specifications
Table 94. Takeda Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Takeda Main Business
Table 96. Takeda Latest Developments
Table 97. 3S Bio Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. 3S Bio Immune Drugs Product Portfolios and Specifications
Table 99. 3S Bio Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. 3S Bio Main Business
Table 101. 3S Bio Latest Developments
Table 102. Horizo??n Therapeutics Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Horizo??n Therapeutics Immune Drugs Product Portfolios and Specifications
Table 104. Horizo??n Therapeutics Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Horizo??n Therapeutics Main Business
Table 106. Horizo??n Therapeutics Latest Developments
Table 107. Bristol-Myers Squibb (BMS Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Bristol-Myers Squibb (BMS Immune Drugs Product Portfolios and Specifications
Table 109. Bristol-Myers Squibb (BMS Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Bristol-Myers Squibb (BMS Main Business
Table 111. Bristol-Myers Squibb (BMS Latest Developments
Table 112. Astellas Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Astellas Immune Drugs Product Portfolios and Specifications
Table 114. Astellas Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Astellas Main Business
Table 116. Astellas Latest Developments
Table 117. Eli Lilly Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Eli Lilly Immune Drugs Product Portfolios and Specifications
Table 119. Eli Lilly Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Eli Lilly Main Business
Table 121. Eli Lilly Latest Developments
Table 122. Mitsubishi Tanabe Pharma Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Mitsubishi Tanabe Pharma Immune Drugs Product Portfolios and Specifications
Table 124. Mitsubishi Tanabe Pharma Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Mitsubishi Tanabe Pharma Main Business
Table 126. Mitsubishi Tanabe Pharma Latest Developments
Table 127. Biogen Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Biogen Immune Drugs Product Portfolios and Specifications
Table 129. Biogen Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Biogen Main Business
Table 131. Biogen Latest Developments
Table 132. Pfizer Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Pfizer Immune Drugs Product Portfolios and Specifications
Table 134. Pfizer Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Pfizer Main Business
Table 136. Pfizer Latest Developments
Table 137. Sanofi Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Sanofi Immune Drugs Product Portfolios and Specifications
Table 139. Sanofi Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Sanofi Main Business
Table 141. Sanofi Latest Developments
Table 142. Roche Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Roche Immune Drugs Product Portfolios and Specifications
Table 144. Roche Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Roche Main Business
Table 146. Roche Latest Developments
Table 147. Novartis Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Novartis Immune Drugs Product Portfolios and Specifications
Table 149. Novartis Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Novartis Main Business
Table 151. Novartis Latest Developments
Table 152. Johnson & Johnson (J&J) Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Johnson & Johnson (J&J) Immune Drugs Product Portfolios and Specifications
Table 154. Johnson & Johnson (J&J) Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Johnson & Johnson (J&J) Main Business
Table 156. Johnson & Johnson (J&J) Latest Developments
Table 157. Amgen Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Amgen Immune Drugs Product Portfolios and Specifications
Table 159. Amgen Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Amgen Main Business
Table 161. Amgen Latest Developments
Table 162. Abbvi Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Abbvi Immune Drugs Product Portfolios and Specifications
Table 164. Abbvi Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Abbvi Main Business
Table 166. Abbvi Latest Developments
Table 1. Immune Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Immune Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immune Boosting Drugs
Table 4. Major Players of Immunosuppressant Drugs
Table 5. Global Immune Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Immune Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Immune Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Immune Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Immune Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Immune Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Immune Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Immune Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Immune Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Immune Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Immune Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Immune Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Immune Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Immune Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Immune Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Immune Drugs Producing Area Distribution and Sales Area
Table 21. Players Immune Drugs Products Offered
Table 22. Immune Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Immune Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Immune Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Immune Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Immune Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Immune Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Immune Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Immune Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Immune Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Immune Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Immune Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Immune Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Immune Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Immune Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Immune Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Immune Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Immune Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Immune Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Immune Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Immune Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Immune Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Immune Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Immune Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Immune Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Immune Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Immune Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Immune Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Immune Drugs
Table 52. Key Market Challenges & Risks of Immune Drugs
Table 53. Key Industry Trends of Immune Drugs
Table 54. Immune Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Immune Drugs Distributors List
Table 57. Immune Drugs Customer List
Table 58. Global Immune Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Immune Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Immune Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Immune Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Immune Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Immune Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Immune Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Immune Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Immune Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Immune Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Immune Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Immune Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Immune Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Immune Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Antares Pharma, Inc. Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Antares Pharma, Inc. Immune Drugs Product Portfolios and Specifications
Table 74. Antares Pharma, Inc. Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Antares Pharma, Inc. Main Business
Table 76. Antares Pharma, Inc. Latest Developments
Table 77. UCB Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. UCB Immune Drugs Product Portfolios and Specifications
Table 79. UCB Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. UCB Main Business
Table 81. UCB Latest Developments
Table 82. Incyte Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Incyte Immune Drugs Product Portfolios and Specifications
Table 84. Incyte Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Incyte Main Business
Table 86. Incyte Latest Developments
Table 87. GSK Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. GSK Immune Drugs Product Portfolios and Specifications
Table 89. GSK Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. GSK Main Business
Table 91. GSK Latest Developments
Table 92. Takeda Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Takeda Immune Drugs Product Portfolios and Specifications
Table 94. Takeda Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Takeda Main Business
Table 96. Takeda Latest Developments
Table 97. 3S Bio Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. 3S Bio Immune Drugs Product Portfolios and Specifications
Table 99. 3S Bio Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. 3S Bio Main Business
Table 101. 3S Bio Latest Developments
Table 102. Horizo??n Therapeutics Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Horizo??n Therapeutics Immune Drugs Product Portfolios and Specifications
Table 104. Horizo??n Therapeutics Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Horizo??n Therapeutics Main Business
Table 106. Horizo??n Therapeutics Latest Developments
Table 107. Bristol-Myers Squibb (BMS Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Bristol-Myers Squibb (BMS Immune Drugs Product Portfolios and Specifications
Table 109. Bristol-Myers Squibb (BMS Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Bristol-Myers Squibb (BMS Main Business
Table 111. Bristol-Myers Squibb (BMS Latest Developments
Table 112. Astellas Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Astellas Immune Drugs Product Portfolios and Specifications
Table 114. Astellas Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Astellas Main Business
Table 116. Astellas Latest Developments
Table 117. Eli Lilly Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Eli Lilly Immune Drugs Product Portfolios and Specifications
Table 119. Eli Lilly Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Eli Lilly Main Business
Table 121. Eli Lilly Latest Developments
Table 122. Mitsubishi Tanabe Pharma Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Mitsubishi Tanabe Pharma Immune Drugs Product Portfolios and Specifications
Table 124. Mitsubishi Tanabe Pharma Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Mitsubishi Tanabe Pharma Main Business
Table 126. Mitsubishi Tanabe Pharma Latest Developments
Table 127. Biogen Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Biogen Immune Drugs Product Portfolios and Specifications
Table 129. Biogen Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Biogen Main Business
Table 131. Biogen Latest Developments
Table 132. Pfizer Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Pfizer Immune Drugs Product Portfolios and Specifications
Table 134. Pfizer Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Pfizer Main Business
Table 136. Pfizer Latest Developments
Table 137. Sanofi Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Sanofi Immune Drugs Product Portfolios and Specifications
Table 139. Sanofi Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Sanofi Main Business
Table 141. Sanofi Latest Developments
Table 142. Roche Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Roche Immune Drugs Product Portfolios and Specifications
Table 144. Roche Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Roche Main Business
Table 146. Roche Latest Developments
Table 147. Novartis Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Novartis Immune Drugs Product Portfolios and Specifications
Table 149. Novartis Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Novartis Main Business
Table 151. Novartis Latest Developments
Table 152. Johnson & Johnson (J&J) Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Johnson & Johnson (J&J) Immune Drugs Product Portfolios and Specifications
Table 154. Johnson & Johnson (J&J) Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Johnson & Johnson (J&J) Main Business
Table 156. Johnson & Johnson (J&J) Latest Developments
Table 157. Amgen Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Amgen Immune Drugs Product Portfolios and Specifications
Table 159. Amgen Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Amgen Main Business
Table 161. Amgen Latest Developments
Table 162. Abbvi Basic Information, Immune Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Abbvi Immune Drugs Product Portfolios and Specifications
Table 164. Abbvi Immune Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Abbvi Main Business
Table 166. Abbvi Latest Developments
LIST OF FIGURES
Figure 1. Picture of Immune Drugs
Figure 2. Immune Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immune Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Immune Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Immune Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Immune Drugs Sales Market Share by Country/Region (2025)
Figure 10. Immune Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Immune Boosting Drugs
Figure 12. Product Picture of Immunosuppressant Drugs
Figure 13. Global Immune Drugs Sales Market Share by Type in 2026
Figure 14. Global Immune Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Immune Drugs Consumed in Hospital
Figure 16. Global Immune Drugs Market: Hospital (2021-2026) & (K Units)
Figure 17. Immune Drugs Consumed in Clinic
Figure 18. Global Immune Drugs Market: Clinic (2021-2026) & (K Units)
Figure 19. Immune Drugs Consumed in Surgery Center
Figure 20. Global Immune Drugs Market: Surgery Center (2021-2026) & (K Units)
Figure 21. Immune Drugs Consumed in Others
Figure 22. Global Immune Drugs Market: Others (2021-2026) & (K Units)
Figure 23. Global Immune Drugs Sale Market Share by Application (2025)
Figure 24. Global Immune Drugs Revenue Market Share by Application in 2026
Figure 25. Immune Drugs Sales by Company in 2026 (K Units)
Figure 26. Global Immune Drugs Sales Market Share by Company in 2026
Figure 27. Immune Drugs Revenue by Company in 2026 ($ millions)
Figure 28. Global Immune Drugs Revenue Market Share by Company in 2026
Figure 29. Global Immune Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Immune Drugs Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Immune Drugs Sales 2021-2026 (K Units)
Figure 32. Americas Immune Drugs Revenue 2021-2026 ($ millions)
Figure 33. APAC Immune Drugs Sales 2021-2026 (K Units)
Figure 34. APAC Immune Drugs Revenue 2021-2026 ($ millions)
Figure 35. Europe Immune Drugs Sales 2021-2026 (K Units)
Figure 36. Europe Immune Drugs Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Immune Drugs Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Immune Drugs Revenue 2021-2026 ($ millions)
Figure 39. Americas Immune Drugs Sales Market Share by Country in 2026
Figure 40. Americas Immune Drugs Revenue Market Share by Country (2021-2026)
Figure 41. Americas Immune Drugs Sales Market Share by Type (2021-2026)
Figure 42. Americas Immune Drugs Sales Market Share by Application (2021-2026)
Figure 43. United States Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Immune Drugs Sales Market Share by Region in 2026
Figure 48. APAC Immune Drugs Revenue Market Share by Region (2021-2026)
Figure 49. APAC Immune Drugs Sales Market Share by Type (2021-2026)
Figure 50. APAC Immune Drugs Sales Market Share by Application (2021-2026)
Figure 51. China Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. India Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Immune Drugs Sales Market Share by Country in 2026
Figure 59. Europe Immune Drugs Revenue Market Share by Country (2021-2026)
Figure 60. Europe Immune Drugs Sales Market Share by Type (2021-2026)
Figure 61. Europe Immune Drugs Sales Market Share by Application (2021-2026)
Figure 62. Germany Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. France Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Immune Drugs Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Immune Drugs Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Immune Drugs Sales Market Share by Application (2021-2026)
Figure 70. Egypt Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Immune Drugs in 2026
Figure 76. Manufacturing Process Analysis of Immune Drugs
Figure 77. Industry Chain Structure of Immune Drugs
Figure 78. Channels of Distribution
Figure 79. Global Immune Drugs Sales Market Forecast by Region (2027-2032)
Figure 80. Global Immune Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Immune Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Immune Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Immune Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Immune Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Immune Drugs
Figure 2. Immune Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immune Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Immune Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Immune Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Immune Drugs Sales Market Share by Country/Region (2025)
Figure 10. Immune Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Immune Boosting Drugs
Figure 12. Product Picture of Immunosuppressant Drugs
Figure 13. Global Immune Drugs Sales Market Share by Type in 2026
Figure 14. Global Immune Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Immune Drugs Consumed in Hospital
Figure 16. Global Immune Drugs Market: Hospital (2021-2026) & (K Units)
Figure 17. Immune Drugs Consumed in Clinic
Figure 18. Global Immune Drugs Market: Clinic (2021-2026) & (K Units)
Figure 19. Immune Drugs Consumed in Surgery Center
Figure 20. Global Immune Drugs Market: Surgery Center (2021-2026) & (K Units)
Figure 21. Immune Drugs Consumed in Others
Figure 22. Global Immune Drugs Market: Others (2021-2026) & (K Units)
Figure 23. Global Immune Drugs Sale Market Share by Application (2025)
Figure 24. Global Immune Drugs Revenue Market Share by Application in 2026
Figure 25. Immune Drugs Sales by Company in 2026 (K Units)
Figure 26. Global Immune Drugs Sales Market Share by Company in 2026
Figure 27. Immune Drugs Revenue by Company in 2026 ($ millions)
Figure 28. Global Immune Drugs Revenue Market Share by Company in 2026
Figure 29. Global Immune Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Immune Drugs Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Immune Drugs Sales 2021-2026 (K Units)
Figure 32. Americas Immune Drugs Revenue 2021-2026 ($ millions)
Figure 33. APAC Immune Drugs Sales 2021-2026 (K Units)
Figure 34. APAC Immune Drugs Revenue 2021-2026 ($ millions)
Figure 35. Europe Immune Drugs Sales 2021-2026 (K Units)
Figure 36. Europe Immune Drugs Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Immune Drugs Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Immune Drugs Revenue 2021-2026 ($ millions)
Figure 39. Americas Immune Drugs Sales Market Share by Country in 2026
Figure 40. Americas Immune Drugs Revenue Market Share by Country (2021-2026)
Figure 41. Americas Immune Drugs Sales Market Share by Type (2021-2026)
Figure 42. Americas Immune Drugs Sales Market Share by Application (2021-2026)
Figure 43. United States Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Immune Drugs Sales Market Share by Region in 2026
Figure 48. APAC Immune Drugs Revenue Market Share by Region (2021-2026)
Figure 49. APAC Immune Drugs Sales Market Share by Type (2021-2026)
Figure 50. APAC Immune Drugs Sales Market Share by Application (2021-2026)
Figure 51. China Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. India Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Immune Drugs Sales Market Share by Country in 2026
Figure 59. Europe Immune Drugs Revenue Market Share by Country (2021-2026)
Figure 60. Europe Immune Drugs Sales Market Share by Type (2021-2026)
Figure 61. Europe Immune Drugs Sales Market Share by Application (2021-2026)
Figure 62. Germany Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. France Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Immune Drugs Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Immune Drugs Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Immune Drugs Sales Market Share by Application (2021-2026)
Figure 70. Egypt Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Immune Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Immune Drugs in 2026
Figure 76. Manufacturing Process Analysis of Immune Drugs
Figure 77. Industry Chain Structure of Immune Drugs
Figure 78. Channels of Distribution
Figure 79. Global Immune Drugs Sales Market Forecast by Region (2027-2032)
Figure 80. Global Immune Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Immune Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Immune Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Immune Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Immune Drugs Revenue Market Share Forecast by Application (2027-2032)
